Voichita Bar‐Ad

2.5k total citations
98 papers, 1.4k citations indexed

About

Voichita Bar‐Ad is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Voichita Bar‐Ad has authored 98 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 40 papers in Otorhinolaryngology and 40 papers in Oncology. Recurrent topics in Voichita Bar‐Ad's work include Head and Neck Cancer Studies (40 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Advanced Radiotherapy Techniques (14 papers). Voichita Bar‐Ad is often cited by papers focused on Head and Neck Cancer Studies (40 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Advanced Radiotherapy Techniques (14 papers). Voichita Bar‐Ad collaborates with scholars based in United States, Canada and Israel. Voichita Bar‐Ad's co-authors include Joseph Curry, David M. Cognetti, Adam Luginbuhl, Madalina Tuluc, Maria Werner‐Wasik, Edmund A. Pribitkin, John D. Sprandio, Jennifer M. Johnson, Wenyin Shi and Joshua D. Palmer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Voichita Bar‐Ad

92 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Voichita Bar‐Ad United States 21 514 447 330 281 273 98 1.4k
J. Biau France 20 440 0.9× 471 1.1× 340 1.0× 329 1.2× 260 1.0× 113 1.3k
Vinita Takiar United States 21 370 0.7× 468 1.0× 487 1.5× 373 1.3× 362 1.3× 100 1.6k
Koh‐ichi Sakata Japan 22 498 1.0× 321 0.7× 303 0.9× 255 0.9× 496 1.8× 85 1.4k
Luca Triggiani Italy 19 324 0.6× 715 1.6× 206 0.6× 198 0.7× 193 0.7× 85 1.2k
K.K. Ang United States 15 580 1.1× 508 1.1× 302 0.9× 340 1.2× 390 1.4× 59 1.4k
Pramod Kumar Julka India 22 326 0.6× 478 1.1× 341 1.0× 92 0.3× 411 1.5× 124 1.6k
Tyler P. Robin United States 17 608 1.2× 405 0.9× 330 1.0× 169 0.6× 272 1.0× 55 1.3k
Cécile Ortholan France 24 668 1.3× 698 1.6× 285 0.9× 399 1.4× 681 2.5× 70 1.8k
Dominic H. Moon United States 14 507 1.0× 607 1.4× 301 0.9× 239 0.9× 138 0.5× 55 1.1k
Yeon‐Sil Kim South Korea 22 546 1.1× 705 1.6× 173 0.5× 507 1.8× 454 1.7× 110 1.6k

Countries citing papers authored by Voichita Bar‐Ad

Since Specialization
Citations

This map shows the geographic impact of Voichita Bar‐Ad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Voichita Bar‐Ad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Voichita Bar‐Ad more than expected).

Fields of papers citing papers by Voichita Bar‐Ad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Voichita Bar‐Ad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Voichita Bar‐Ad. The network helps show where Voichita Bar‐Ad may publish in the future.

Co-authorship network of co-authors of Voichita Bar‐Ad

This figure shows the co-authorship network connecting the top 25 collaborators of Voichita Bar‐Ad. A scholar is included among the top collaborators of Voichita Bar‐Ad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Voichita Bar‐Ad. Voichita Bar‐Ad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Linnenbach, Alban J., Voichita Bar‐Ad, Adam Luginbuhl, et al.. (2024). Abstract 2293: Comparisons of saliva versus plasma cfDNA and exosomal DNA as potential biomarkers for head and neck cancer. Cancer Research. 84(6_Supplement). 2293–2293.
3.
Ohri, Nitin, et al.. (2023). Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study. JCO Clinical Cancer Informatics. 7(7). e2200132–e2200132. 3 indexed citations
4.
Manukian, Gregor, Jennifer M. Johnson, Rita Axelrod, et al.. (2023). In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 117(1). 181–185. 3 indexed citations
6.
Thor, Maria, Joseph O. Deasy, Chen Hu, et al.. (2020). Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clinical Cancer Research. 26(17). 4643–4650. 45 indexed citations
7.
Song, Andrew, Voichita Bar‐Ad, Nina Martinez, et al.. (2020). Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology. 147(3). 653–661. 20 indexed citations
8.
Roden, Dylan F., Richard A. Goldman, Jennifer M. Johnson, et al.. (2019). Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment. Head & Neck. 41(12). 4128–4135. 11 indexed citations
9.
Song, Andrew, David W. Andrews, Maria Werner‐Wasik, et al.. (2019). Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas. Radiotherapy and Oncology. 132. 135–141. 24 indexed citations
10.
Doyle, Laura, et al.. (2019). Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer. Journal of Contemporary Brachytherapy. 11(3). 221–226. 4 indexed citations
11.
Palmer, Joshua D., Deepak Bhamidipati, Andrew Song, et al.. (2018). Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?. Journal of Neuro-Oncology. 140(3). 623–628. 31 indexed citations
12.
Topf, Michael C., Voichita Bar‐Ad, Adam Luginbuhl, et al.. (2018). AJCC-8ed nodal staging does not predict outcomes in surgically managed HPV-associated oropharyngeal cancer. Oral Oncology. 82. 138–143. 16 indexed citations
14.
Alexander, Gregory S., Joshua D. Palmer, Madalina Tuluc, et al.. (2016). Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. Journal of Hematology & Oncology. 9(1). 96–96. 21 indexed citations
15.
Bar‐Ad, Voichita, Joshua D. Palmer, Yinzhi Lai, et al.. (2016). Neutrophil to lymphocyte ratio associated with prognosis of lung cancer. Clinical & Translational Oncology. 19(6). 711–717. 37 indexed citations
16.
Williams, Noelle L., Joshua D. Palmer, Voichita Bar‐Ad, et al.. (2015). Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature. PubMed. 1(1). 3–6. 11 indexed citations
17.
Yeung, Vincent, Joshua D. Palmer, Noelle L. Williams, et al.. (2015). Adenosquamous Carcinoma of the Pancreas in a Patient with BRCA2 Mutation: A Case Report. PubMed. 1(1). 22–25. 2 indexed citations
18.
Shi, Wenyin, Yaacov Richard Lawrence, Hak Choy, et al.. (2014). Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial. Journal of Neuro-Oncology. 118(2). 313–319. 28 indexed citations
19.
Witek, Matthew E., Joshua Siglin, Adam E. Snook, et al.. (2014). Is Financial Literacy Necessary for Radiation Oncology Residents?. International Journal of Radiation Oncology*Biology*Physics. 90(5). 986–987. 14 indexed citations
20.
Zaorsky, Nicholas G., Timothy N. Showalter, Robert B. Den, et al.. (2013). Impact of a Radiation Oncology Elective on the Careers of Young Physicians: Update on a Prospective Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 86(2). 214–215. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026